Concepedia

Publication | Closed Access

Randomized, Controlled Trial of OROS Methylphenidate Once a Day in Children With Attention-Deficit/Hyperactivity Disorder

DOI

508

Citations

15

References

2001

Year

Mark L. Wolraich, Laurence L. Greenhill, William E. Pelham, James M. Swanson, Timothy E. Wilens, Donna Palumbo, Marc S. Atkins, Keith McBurnett, Oscar G. Bukstein, Gerald J. August
PEDIATRICS

Abstract

For the treatment of core ADHD symptoms, OROS MPH dosed qd and IR MPH dosed tid were superior to placebo and were not significantly different from each other.attention-deficit/hyperactivity disorder, methylphenidate, OROS, Concerta.

References

YearCitations

Page 1